Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Antigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccines.

Wang S, Mboudjeka I, Goguen JD, Lu S.

Vaccine. 2010 Feb 23;28(8):2011-9. doi: 10.1016/j.vaccine.2009.10.059.

2.

Relative immunogenicity and protection potential of candidate Yersinia Pestis antigens against lethal mucosal plague challenge in Balb/C mice.

Wang S, Joshi S, Mboudjeka I, Liu F, Ling T, Goguen JD, Lu S.

Vaccine. 2008 Mar 20;26(13):1664-74. doi: 10.1016/j.vaccine.2008.01.024. Epub 2008 Feb 4.

3.

Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen.

Grosfeld H, Cohen S, Bino T, Flashner Y, Ber R, Mamroud E, Kronman C, Shafferman A, Velan B.

Infect Immun. 2003 Jan;71(1):374-83.

4.

A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague.

Yamanaka H, Hoyt T, Yang X, Golden S, Bosio CM, Crist K, Becker T, Maddaloni M, Pascual DW.

Infect Immun. 2008 Oct;76(10):4564-73. doi: 10.1128/IAI.00581-08. Epub 2008 Aug 11.

5.

A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague.

Wang S, Heilman D, Liu F, Giehl T, Joshi S, Huang X, Chou TH, Goguen J, Lu S.

Vaccine. 2004 Sep 3;22(25-26):3348-57.

PMID:
15308359
6.

Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.

Leary SE, Griffin KF, Garmory HS, Williamson ED, Titball RW.

Microb Pathog. 1997 Sep;23(3):167-79.

PMID:
9281474
8.

Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid.

Boyer JL, Sofer-Podesta C, Ang J, Hackett NR, Chiuchiolo MJ, Senina S, Perlin D, Crystal RG.

Hum Gene Ther. 2010 Jul;21(7):891-901. doi: 10.1089/hum.2009.148.

9.

An IL-12 DNA vaccine co-expressing Yersinia pestis antigens protects against pneumonic plague.

Yamanaka H, Hoyt T, Bowen R, Yang X, Crist K, Golden S, Maddaloni M, Pascual DW.

Vaccine. 2009 Jan 1;27(1):80-7. doi: 10.1016/j.vaccine.2008.10.021. Epub 2008 Oct 26.

10.

Immunization of mice with YscF provides protection from Yersinia pestis infections.

Matson JS, Durick KA, Bradley DS, Nilles ML.

BMC Microbiol. 2005 Jun 24;5:38.

11.

Immunogenicity and efficacy of an anthrax/plague DNA fusion vaccine in a mouse model.

Albrecht MT, Eyles JE, Baillie LW, Keane-Myers AM.

FEMS Immunol Med Microbiol. 2012 Aug;65(3):505-9. doi: 10.1111/j.1574-695X.2012.00974.x. Epub 2012 May 21.

12.

Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine.

Erova TE, Rosenzweig JA, Sha J, Suarez G, Sierra JC, Kirtley ML, van Lier CJ, Telepnev MV, Motin VL, Chopra AK.

Clin Vaccine Immunol. 2013 Feb;20(2):227-38. doi: 10.1128/CVI.00597-12. Epub 2012 Dec 12.

13.

Protective immunity in mice achieved with dry powder formulation and alternative delivery of plague F1-V vaccine.

Huang J, D'Souza AJ, Alarcon JB, Mikszta JA, Ford BM, Ferriter MS, Evans M, Stewart T, Amemiya K, Ulrich RG, Sullivan VJ.

Clin Vaccine Immunol. 2009 May;16(5):719-25. doi: 10.1128/CVI.00447-08. Epub 2009 Mar 4.

14.

Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccines.

Tao P, Mahalingam M, Kirtley ML, van Lier CJ, Sha J, Yeager LA, Chopra AK, Rao VB.

PLoS Pathog. 2013;9(7):e1003495. doi: 10.1371/journal.ppat.1003495. Epub 2013 Jul 11.

15.

Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts.

Arlen PA, Singleton M, Adamovicz JJ, Ding Y, Davoodi-Semiromi A, Daniell H.

Infect Immun. 2008 Aug;76(8):3640-50. doi: 10.1128/IAI.00050-08. Epub 2008 May 27.

16.

Yersinia pestis caf1 variants and the limits of plague vaccine protection.

Quenee LE, Cornelius CA, Ciletti NA, Elli D, Schneewind O.

Infect Immun. 2008 May;76(5):2025-36. doi: 10.1128/IAI.00105-08. Epub 2008 Mar 17.

17.

Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.

Sabhnani L, Manocha M, Sridevi K, Shashikiran D, Rayanade R, Rao DN.

FEMS Immunol Med Microbiol. 2003 Oct 15;38(3):215-29.

18.

A parenteral DNA vaccine protects against pneumonic plague.

Yamanaka H, Hoyt T, Yang X, Bowen R, Golden S, Crist K, Becker T, Maddaloni M, Pascual DW.

Vaccine. 2010 Apr 19;28(18):3219-30. doi: 10.1016/j.vaccine.2010.02.022. Epub 2010 Mar 1.

19.

Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis.

Honko AN, Sriranganathan N, Lees CJ, Mizel SB.

Infect Immun. 2006 Feb;74(2):1113-20.

20.

Oral vaccination with salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague.

Yang X, Hinnebusch BJ, Trunkle T, Bosio CM, Suo Z, Tighe M, Harmsen A, Becker T, Crist K, Walters N, Avci R, Pascual DW.

J Immunol. 2007 Jan 15;178(2):1059-67.

Supplemental Content

Support Center